The surgical approach to repair of tetralogy of Fallot (ToF) has shifted over the years. We aimed to report the long-term follow-up after ToF repair with the transatrial-transpulmonary approach and to determine predictors of long-term outcomes.
INTRODUCTION
Surgical correction of tetralogy of Fallot (ToF) is reported to date back as early as 1954. Since then, major developments have resulted in excellent present-day survival in ToF patients, which is, however, still reduced compared with the overall population [1] .
Over the years, the surgical approach to ToF has shifted from a repair via a right ventriculotomy, commonly combined with a patch in the right ventricular outflow tract (RVOT), often after initial palliative shunting, to a transatrial-transpulmonary approach often as primary repair [1] . The aim of the latter approach was to minimize the unfavourable side effects associated with a ventriculotomy, such as transmural myocardial scarring and coronary artery damage, which were thought to contribute to long-term impairment of right ventricular function and the risk of ventricular arrhythmias [2] .
Long-term complications like decreased exercise tolerance, (right) heart failure, arrhythmias and sudden death are well known to occur after repair of ToF [2] . Pulmonary valve replacement (PVR) and, to a lesser extent, internal cardiodefibrillator (ICD) placement are common procedures in the long-term after repair of ToF.
Predictors for negative long-term outcomes after ToF repair have been studied extensively and include the amount of residual pulmonary regurgitation (PR), right and left ventricular size and function, myocardial tissue composition, right ventricular outflow function and electrical inhomogeneity [2] [3] [4] [5] [6] . Despite extensive literature on the results of ToF repair, relatively limited information is available specifically on the long-term outcomes of the transatrial-transpulmonary approach. Many studies of the long-term outcomes of ToF repair have not focussed on the outcomes of this approach, have used different criteria to define the population with ToF that was included or have been hampered by small patient numbers or a short duration of follow-up [7, 8] .
The aims of this study were to report the long-term follow-up after ToF repair with the transatrial-transpulmonary approach in a relatively large cohort and to determine predictors of long-term adverse outcomes.
PATIENTS AND METHODS

Patients
A retrospective analysis was made of all patients who underwent ToF repair with a transatrial-transpulmonary approach in two tertiary referral centres in the Netherlands, with special attention to whether a transannular patch (TP) was used or not (non-TP). Data of all patients born after 1 January 1970 and who had undergone ToF repair were analysed. ToF was defined as ventricular septal defect with anterior deviation of the outflow septum, without major anomalies, requiring desobstruction of right ventricular outflow obstruction and closure of ventricular septal defect. Patients with other diagnoses including pulmonary atresia (PA), double outlet right ventricle (DORV), atrioventricular septal defect (AVSD) and absent pulmonary valve syndrome (APVS) were excluded. Other exclusion criteria were patients whose surgical reports were not available, patients with insufficient follow-up data and patients who did not have a transatrial-transpulmonary ToF repair.
In general, in all the years of the study, the transatrial-transpulmonary strategy essentially consisted of right atriotomy as the first step in the approach of the VSD and the RVOT. As the second step, the main pulmonary artery was opened with a longitudinal incision as an approach to the pulmonary valve and the subvalvular area. Only after endoventricular desobstruction of the RVOT and when considered necessary by the attending surgeon, this incision was continued along the length of the infundibulum and reconstructed with a TP to create an adequate diameter of the RVOT. Patients in whom primarily a ventriculotomy was performed were excluded from our study.
Patients were included if treated in the Erasmus Medical Centre (EMC), Rotterdam, or the Radboud University Medical Centre Nijmegen (RUMC), Nijmegen, the Netherlands.
The study complies with the regulations of institutional review boards with regard to retrospective data collection.
METHODS
Data collection
The medical and surgical records of all patients were reviewed. Demographic characteristics are given in Table 1 . Characteristics of the ToF repair including operative techniques and preoperative parameters were collected (Table 2) . Postoperative complications were scored.
Primary outcomes were defined as death, PVR, late reoperations other than PVR, balloon dilatations for pulmonary stenosis (PS) and the placement of an ICD or pacemaker. Patient status was checked in the municipal basic administration (GBA) in the Netherlands. Patients lost to follow-up were censored at the last known follow-up date according to hospital records and/or the municipal basic administration. We recorded and analysed the last outpatient visits for all patients in the period from 1 January 2010 until 30 June 2012. Collected parameters were: length, weight, use of medication, QRS duration and QTc time (corrected QT-time) on ECG, severity of PR, PS and RV dilatation on echocardiography and VO 2 max, maximal work load and maximal heart rate at graded step-wise bicycle cardiopulmonary exercise testing. The presence of residual PS was recorded if a mean echocardiographic gradient of ≥16 mmHg was present. The severity of pulmonary and tricuspid regurgitation (TR) was assessed semi-quantitatively on echocardiography [9] . MRI data obtained in relation to the latest outpatient visit were recorded. MRI volumetric data were indexed to body surface area.
Complications after ToF repair were defined as infection, arrhythmia, early reoperation (within 30 days of complete repair), fluid retention and prolonged use of inotropic drugs (>48 h).
Data analysis
Statistical analysis was performed with IBM SPSS Statistics 20 (SPSS, Inc., USA). We tested with a significance level of 0.05.
Data were summarized for all patients using frequencies and percentages for categorical variables and either mean ± standard deviation (SD) or median with range for numerical variables.
A Student's t-test was used to compare means between independent groups. In case a value did not have a normal distribution, we calculated the medians and used a (non-parametric) Mann-Whitney test to compare these medians between the groups. We used a χ 2 test to compare categorical variables with a normal distribution between independent subgroups. When a categorical value was not distributed normally, Fisher's exact With a Cox proportional hazard analysis (forward step-wise regression method), we analysed whether parameters had an influence on the probability of an event. The seven best parameters in univariate analysis were included in the multivariate analysis. We composed a composite endpoint, which was defined as death, PVR, other (late: >30 days after complete repair) reoperations, balloon dilatations for PS or pacemaker insertion.
RESULTS
Patient characteristics
We identified 465 patients who met the inclusion criteria, as shown in Fig. 1 ; 288 patients from Centre 1 and 165 from Centre 2 were included. Twelve patients were excluded because they were lost to follow-up. Eleven patients had their ToF repair in the Netherlands but lived abroad and were lost to follow-up. In 1 patient, the follow-up was insufficient. Table 1 summarizes patient characteristics of the 453 patients; 63.1% were male. In 96.2% of the patients, associated cardiac anomalies were found: secundum type atrial septal defect in 82.3%, patent ductus arteriosus in 20.4%, uni-and bicuspid pulmonary valve in, respectively, 6.7 and 52.3%. A coronary artery had an aberrant origin in 5% of the patients and 16.1% of patients had a right aortic arch.
Prior to TOF repair, 12.8% of the patients received a palliative shunt, as shown in Table 1 . This percentage was significantly higher in the patients who later received a TP compared with those who did not [15% (n = 45) vs 8% (n = 13) (P = 0.030)]. Mean PS gradient before complete repair was higher in the TP group compared with the non-TP group [80 ± 24 (n = 134) vs 66 ± 25 (n = 90) mmHg (P < 0.001)]. The median age at repair of ToF was 0.6 (0-19.6) years, as shown in Table 2 . Of the 453 patients, a TP was used in 215 (47.5%) patients, and both a TP and valvotomy were done in 79 (17.4%). In further analysis, these 294 patients were termed the TP group. In 98 (21.6%) patients, only pulmonary valvotomy was performed, and in 61 (13.5%) patients no valvotomy and no TP were required. These patients were included as the non-TP group (n = 159).
A total of 20 patients received an early reoperation within 30 days of ToF repair, as shown in Table 2 . Eleven patients needed rethoracotomy due to a rebleeding, 7 due to a residual VSD and 2 because of residual RVOT obstruction.
A trend towards decreasing median age at ToF repair over time was noted: in the cohort 1970-80 median age at repair was 1. A total of 77 (17.0%) patients were diagnosed with a genetic syndrome or association. In 28 patients this concerned trisomy 21, in 25 patients 22q11 deletion, in 7 patients vertebral anomalies, anal atresia, cardiac defects, tracheoesophageal fistula and/or esophageal atresia, renal & radial anomalies and limb defects (VACTERL) association and in 17 patients a range of individual gene abnormalities, syndromes or associations.
Survival and event-free survival
Sixteen patients died during follow-up. This represents 3.5% of the study population. Early mortality (within 30 days of ToF repair) Figure 2 shows the cumulative overall survival for patients with and those without a TP. Survival for the TP group was 97.2% (95% CI 95.2-99.2) at 10 years and 91.0% (95% CI 83.9-98.1) at 25 years after ToF repair, compared with 97.5% (95% CI 95.1-99.9) at 10 years and 96.3% (95% CI 93.0-99.6) at 25 years in the non-TP group (P = 0.958).
The cumulative overall event-free survival was 80.7% (95% CI 76.9-84.6) at 10 years and 37.0% (95% CI 27.2-46.8) at 25 years after ToF repair. In Fig. 3 , the event-free survival is shown for the patients with and those without a TP. For the TP group, the cumulative total event-free survival is 80.2% (95% CI 75.5-84.9) at 10 years and 27.6% (95% CI 17.7-38.1) at 25 years; for the non-TP group, it is 81.7% (95% CI 75.2-88.2) at 10 years and 78.5% (95% CI 71.4-85.6) at 25 years after ToF repair. The differences in eventfree survival were statistically significant (P = 0.016).
Long-term outcomes
In Table 3 , the long-term outcomes of all patients are shown. The patients are divided into two groups: TP (n = 294) and non-TP (n = 159). The median age at the end of the follow-up period for the entire cohort is 14.4 (0.1-42.1) years. There was no significant difference between the median age at the end of follow-up between the two subgroups.
A total of 52 patients underwent a first PVR; this was 11.5% of the study population. The first PVR was performed at a median of 20.2 (1.9-34.8) years after the ToF repair. In the TP group, 51 (17.3%) patients received a PVR, and in the non-TP group only 1 patient (0.6%) did (P < 0.001).
As shown in Table 3 , a total of 72 (15.9%) patients needed a late reoperation other than PVR, 17.0% in the TP group and 13.8% in the non-TP goup (P = not significant). Reoperations performed were infundibulectom (desobstruction of the RVOT) combined with reconstruction of the pulmonary artery in 3.3% of all patients. Isolated infundibulectomy (RVOT desobstruction) was performed in 4.9% of all patients and isolated reconstruction of the pulmonary was performed in 1.8% of all patients.
Clinical state at latest evaluation
In Table 4 , information regarding the last outpatient visit between 2010 and 2012 is given. Three hundred and sixty patients were seen in that setting in this period, 49 of whom had had a PVR.
Patients in the PVR group were significantly older than those in the non-PVR group: 27.7 (10.9-42.1) compared with 11.7 (0.3-36.1) years (P < 0.001). The median age at follow-up post-ToF repair was also significantly higher in the PVR group.
Electrocardiography was performed in 341 patients and QRS duration was assessed in 324 patients. A significant difference (P < 0.001) was found in mean QRS duration between the two groups. In the PVR group, the mean QRS duration was 136 ± 25 ms, compared with 119 ± 25 ms in the non-PVR group. The mean QRS duration in all patients was 121 ± 26 after a mean follow-up of 12 years, and 5 patients had a QRS duration of more than 180 ms.
In 298 patients, an echocardiogram was performed. Seventeen percent of patients had no RV dilatation; mild dilatation was found in 32% of patients, moderate dilatation in 48% and severe dilatation in 2%. Echocardiography did not show statistically significant differences for RV size between the TP and non-TP groups.
A more than minimal residual PS gradient was found in 70% of the patients. Patients in the PVR group had significantly more PS than those in the non-PVR group: 90.0% compared with 66.2% (P = 0.009).
In 246 patients, TR was noted at echocardiography. No TR was found in 21.5% of the patients, mild TR in 67.4% and moderate TR in 10.6%. In 0.4% of the patients, severe TR was found. Two patients with moderate TR underwent a PVR and the patient with severe TR had a pacemaker due to a third-degree heart block. Table 5 presents the results of Cox proportional hazard analysis of the most important parameters for the combined event. Univariate analysis showed that the use of a TP during ToF repair was associated with a higher probability of an event (HR 1.631, 95% CI 1.077-2.471). Also, postoperative complications after ToF repair (HR 1.506, 95% CI 1.035-2.191), year of TOFr (HR 1.034, 95% CI 1.007-1.061) and age at TOFr (HR 0.987, 95% CI 0.976-0.997) were associated with a higher risk. The parameters Hb level before ToF repair, male gender and the presence of a genetic disorder did not show a significant association in univariate analysis.
Predictors for negative outcomes
In multivariate analysis, both the use of a TP (HR 1.705, 95% CI 1.023-2.842) and year of TOFr (HR 1.039, 95% CI 1.006-1.073) were associated with a higher probability of an event.
In hazard analysis for the event death, both uni-and multivariate analyses did not show significant associations.
DISCUSSION
This study shows that overall, ToF patients corrected with the transatrial-transpulmonary approach have excellent survival rates. Over several decades, the operative mortality (5 of 453 patients) was 1.1%, and 25-year overall survival rate was 92%, more specifically 91% in the TP group and 96% in the non-TP group. In the time-span we studied, there was a clear trend towards repair at younger age and a decrease in the use of transannular patching of the RVOT, confirming other reports on this subject.
Whereas 10-to 15-year survival has been documented frequently in various cohorts of ToF, relatively few studies have reported on 25-year survival after ToF repair. In 2008, a group from Toronto reported a 25-year survival of 90% for ToF without PA, DORV, AVSD or branch PS, in patients born before 1984 [10] . Recently, 25-year overall survival in a large Korean cohort was reported to be 93%, with statistically better survival for transatrial and non-transannular approaches [11] . The improvements in survival, in part, relate to improved early mortality [10] . While long-term deterioration of clinical state and the need for reinterventions are commonly recognized, it is less clear whether the mortality risk increases with time [10] . Considering the low rate of late mortality in our patients, this could not be assessed from our data. Of note, only 3.5% of the patients died, many of whom had associated genetic abnormalities. Most of these patients were relatively young at time of death. The number of patients who died late in follow-up in our cohort is very low. The explanation probably lies in the fact that with the surgical approach as described, these patients are in good clinical condition after ToF repair and apparently have a good prognosis with regard to survival for the observed period [6, 12] .
Timely reintervention is another factor to consider. In fact, there is a clear increase of reinterventions with time, particularly after 15-year follow-up. There was a clear difference in event-free survival for the TP versus the non-TP group. Multivariate analysis demonstrated that the use of a TP in the setting of transatrialtranspulmonary approach was associated with a 1.7 times higher risk of the composite endpoint of death, PVR, reoperation for other reasons, balloon dilatation for PS or pacemaker placement in our patients. This confirms findings from earlier reports in combined cohorts [2] . Since the use of a TP depends on the anatomy and haemodynamics at initial repair and often cannot be avoided, this emphasizes the importance of comparison of results among clearly defined and highly comparable populations [5, 10, 13] Event-free survival differs significantly from overall survival in most series. The majority of reinterventions are related to the long-term effects of PR and particularly consist of PVR. At a median follow-up of 15 years, 17% of our patients who had transannular patching of their RVOT at the initial repair had PVR; this compares favourably with similar reports in the literature [10, 11] . Patients without a TP had better event-free survival. These types of observations resulted in attempts to avoid transannular patching and avoid damage to the pulmonary valve and/or infundibulum [1, 8] .
Recently, Bove et al. [8] demonstrated in an experimental setting that of the available alternatives, extensive transannular patching results in the most severely dilated and functionally impaired right ventricles. Whether the alternative TP-avoiding strategies will result in improved (event-free) survival of patients is to be seen; in earlier studies, this could not be demonstrated [5, 8] . The trade-off of restrictive strategies aimed to avoid residual PR may be an increased reoperation rate for residual stenosis [8] . Preliminary data from a large registry study may point towards an increased risk of arrhythmias and sudden death in patients with residual RV outflow obstruction and RV hypertrophy [14] . The long-term problems related to chronic PR are well known and include right ventricular dilatation, impaired right and left ventricular function and increased risk of arrhythmias. Risk factors for late problems related to PR have been identified and include the amount of residual PR, right and left ventricular size and function, myocardial tissue composition, right ventricular infundibular and outflow tract function, right atrial function and electrical inhomogeneity [2] [3] [4] [5] 15] . Many of these risk factors cannot be fully avoided, despite individualized operative strategies aimed at preservation of RVOT function.
A remarkable finding of our study is the lack of improvement in exercise performance, pro-arrhythmic ECG parameters, ventricular size and an increase in RVOT stenosis in patients after PVR. Although this data must be interpreted with caution considering the limited number of observations for some parameters, this questions the timing and effects of PVR. Considerable debate exists with regard to indications for PVR. Current guidelines include factors from history, ECG signs of increased electrical inhomogeneity and haemodynamic factors related to residual RVOT problems [14] . These factors include older age at repair and ECG parameters, particularly QRS duration. Recommendations with regard to RV size provide a wide range of end-diastolic dimensions, from ±140 to ±180 ml/m 2 body surface area [16, 17] . In this size range of the RV, normalization of systolic RV function after restoration of pulmonary valve competency and resection of the dilated RV outflow has been demonstrated. Whether this results in improved long-term survival has not yet been established [18] . Recent data suggest that patients with intermediate RV dilatation (132 ± 9 ml/m 2 ) and severe PR (40 ± 3%) are at low risk of significant progression of RV size in the short term, suggesting that some delay in PVR may be acceptable in this group [19] . PVR may also induce some degree of RVOT stenosis, as was noted in our patient group. This could be caused by the use of a relatively small homograft or by deterioration of the homograft [20] .
The lack of change in important pro-arrhythmic parameters, such as QRS duration and QTc time, reflects earlier observations [18] . In a study that has been criticized for problems related to adequate matching of the groups involved, Harrild et al. [18] could not demonstrate a beneficial effect of PVR with regard to post-PVR occurrence of ventricular tachycardia or death. The implications of these observations are that current long-term treatment strategies may require modification [14] .
A common indication for reintervention after ToF repair is prevention or treatment of haemodynamically important arrhythmias. The burden of arrhythmias is considerable in these patients, particularly in the adult age range. Atrial arrhythmias occur frequently, in up to one-third of the patients [21] Pacemaker implantation, for bradycardia and tachycardia/bradycardia syndromes, is required in up to 8% [21] . Haemodynamic factors and prior surgeries are among the most important risk factors. In our population, pacemaker implantation was relatively infrequent and was required only in the TP group.
More than moderate TR may be another indication for reintervention. The occurrence of more than minimal TR in our series was limited and comparable/compares favourably with other recent reports. Important TR may relate to intrinsic valve abnormalities, traction on the tricuspid annulus or damage to tricuspid structures during repair or to RV dilatation in the setting of impaired RV function [22] . In recent series, late TR did not differ between transatrial and transventricular approaches to ToF repair [3, 6] .
Since the 1970s, less than 10% of ToF repairs in our institutions have been performed with the transventricular approach, which has hampered a direct comparison between results of transatrial and transventricular repairs. Recent single-and multicentre data suggest that both techniques can be used successfully. Ventriculotomy has been thought to contribute to long-term impairment of right ventricular function and the risk of ventricular arrhythmias. Whether the transatrial-transpulmonary approach has actually resulted in long-term benefits for the patients is still a subject of debate. The transatrial-tranpulmonary approach does not use a ventriculotomy in the body of the RV and a limited, if any, incision of the RV outflow tract. Comparison of results is often difficult, since different approaches in time, different anatomical variants and different age groups have been included in different studies. Furthermore, the long-term effects of the approach to VSD closure and of RV outflow desobstruction are hard to distinguish. Lindberg et al. [5] in a single-centre study of 570 patients did not find any difference in long-term outcomes of transatrial versus transventricular repair. Any transannular incision increased the risk of reinteventions, but did not impact on long-time survival [5, 11] . In the series of Alexiou et al. [23] , a significantly higher reintervention rate at 10-and 20-year follow-up was noted in the atrial versus the transventricular approach, particularly for RV outflow obstruction, for reasons that were not clear to the authors. This has not been a common observation [5, 6] . Data from the Society of Thoracic Surgeons Database and of the European Association for Cardio-Thoracic Surgery Congenital Database have shown that both approaches continue to be used widely, with excellent early results and ventriculotomy and TP as the most prevalent type of operation [3, 4] . A temporal trend towards the transatrial approach has been reported in the most recent studies [3, 24] .
Study limitations
A limitation of this study is the retrospective design, resulting in a considerable number of missing values. Another limitation was the small number of patients with an event. Furthermore, a direct comparison of different surgical approaches could not be made.
Conclusions
ToF patients corrected with the transatrial-transpulmonary approach have good long-term survival. Clinical condition after ToF repair is good; PVR is a frequent event at longer follow-up, other events are limited in number. The use of a TP at ToF repair is a predictor for poorer event-free outcome; it almost doubles the risk of the composite endpoint of death, reoperation, balloon dilatation, pacemaker placement or PVR.
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